Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The study is designed to test the hypothesis in healthy subjects that the oral antidiabetic
drug rosiglitazone provides additional vascular relaxing or modulating effects in addition to
its blood glucose level reducing ability.